Patents by Inventor Ursula Kapp

Ursula Kapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080167264
    Abstract: Materials and methods are disclosed for modulating proliferation of cell types associated with Hodgkin's disease through inhibition of IL-13 and components in IL-13 associated signal transduction pathways. Methods to identify inhibitors, compositions comprising the inhibitors, and methods using the inhibitors to treat Hodgkin's disease are also disclosed.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 10, 2008
    Applicant: AMGEN INC.
    Inventors: Tak W. Mak, Ursula Kapp
  • Patent number: 7312024
    Abstract: Materials and methods are disclosed for modulating proliferation of cell types associated with Hodgkin's disease through inhibition of IL-13 and components in IL-13 associated signal transduction pathways. Methods to identify inhibitors, compositions comprising the inhibitors, and methods using the inhibitors to treat Hodgkin's disease are also disclosed.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: December 25, 2007
    Assignee: Amgen Canada Inc.
    Inventors: Tak W. Mak, Ursula Kapp
  • Publication number: 20030049257
    Abstract: Materials and methods are disclosed for modulating proliferation of cell types associated with Hodgkin's disease through inhibition of IL-13 and components in IL-13 associated signal transduction pathways. Methods to identify inhibitors, compositions comprising the inhibitors, and methods using the inhibitors to treat Hodgkin's disease are also disclosed.
    Type: Application
    Filed: October 21, 2002
    Publication date: March 13, 2003
    Inventors: Tak W. Mak, Ursula Kapp
  • Patent number: 6468528
    Abstract: Materials and methods are disclosed for modulating proliferation of cell types associated with Hodgkin's disease through inhibition of IL-13 and components in IL-13 associated signal transduction pathways. Methods to identify inhibitors, compositions comprising the inhibitors, and methods using the inhibitors to treat Hodgkin's disease are also disclosed.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: October 22, 2002
    Assignee: Amgen Canada Inc.
    Inventors: Tak W. Mak, Ursula Kapp